Research Library

The Retatrutide Research Library

Reviewed, referenced explainers on the pharmacology of retatrutide (LY3437943) and how to source research-grade material — written for a laboratory audience. Every article is reviewed by the RETApro Research Team and carries a “last reviewed” date. Retatrutide is an investigational compound supplied for laboratory research use only.

Reviewed articles

Mechanism

Retatrutide’s mechanism of action

How the triple agonist engages the GIP, GLP-1, and glucagon receptors, its structure, and the primary literature behind it.

Comparison

Retatrutide vs tirzepatide vs semaglutide

A receptor and structural comparison across the incretin class — by target, class, half-life, and development stage.

Due diligence

How to evaluate a research peptide supplier

A buyer’s checklist: reading a Certificate of Analysis, verifying purity by HPLC and MS, traceability, storage, and buyer verification.

Related guides

The RETApro research library is scientific and educational information about an investigational research compound and is not medical advice. Retatrutide (LY3437943) is not approved by the MHRA, FDA, or any regulator and is supplied strictly for laboratory and research use only — not for human or veterinary use.